Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Global Syringes Market, By Type (General, Specialized {Insulin, Allergy, Tuberculin, Others}, Smart {Auto-Disable, Active Safety, Passive Safety}) By Material, By Usability, By End User, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering. The global syringes market is expected to show impressive growth in the next five years owing to the increase in the number of self-administration of vaccines by patients and the rise in the number of diseases requiring injections as a drug delivery method.

Also, the ongoing advancements in technology, such as the development of smart syringes, are expected to create numerous growth opportunities for the global syringes market. Smart syringes have advanced functions like auto-disable and active-passive safety, which is expected to fuel their demand in the coming years. The global syringes market is segmented based on type, material, usability, end user, and regional distribution. Based on type, the market is categorized into general, specialized syringes, and smart syringes. Specialized syringes are specific for a certain purpose and are differentiated into insulin, allergy, tuberculin, and others. Specialized syringes are specific to a field and are picking up the market growth pace, whereas the general syringes are expected to dominate the market segment in the upcoming five years. North America dominates the market and is expected to maintain its dominance over the next five years. The major driving factors for the market in the region are the surge in the number of investors and the high chronic disease prevalence. Consumers have become more health-conscious and are willing to spend a significant amount on improving their health. Some of the major competitors in the global syringes market are Becton, Dickinson, and Company, Terumo Corporation, Medtronic plc, B. Braun Medical Inc., Nipro Corporation, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, CODAN Medizinische Gerate GmbH & Co KG, Baxter International, Inc., West Pharmaceutical Services, Inc., Retractable Technologies, Inc., Biocon Limited, Owen Mumford Ltd, Shandong Weigao Group Medical Polymer Co., Ltd., among others. Years considered for this report:

To analyze the historical growth in the market size of global syringes market from 2017 to 2021

To estimate and forecast the market size of global syringes market from 2022E to 2027F and growth rate until 2027F

To classify and forecast global syringes market based on type, material, usability, end user, and regional distribution

To identify dominant region or segment in the global syringes market

To identify drivers and challenges for global syringes market

To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global syringes market

To identify and analyze the profile of leading players operating in global syringes market

To identify key sustainable strategies adopted by market players in global syringes market

Key Topics Covered: 1. Product Overview 2. Research Methodology 3. Executive Summary 4. Voice of Customer 5. Impact of COVID-19 on Global Syringes Market 6. Global Syringes Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type (General, Specialized, Smart) 6.2.1.1. Specialized Syringes (Insulin, Allergy, Tuberculin, Others) 6.2.1.2. Smart Syringes (Auto-Disable, Active Safety, Passive Safety) 6.2.2. By Material (Glass Syringes v/s Plastic Syringes) 6.2.3. By Usability (Reusable Syringes v/s Disposal Syringes) 6.2.4. By End User (Hospitals & Clinics, Blood Collection Centers, Ambulatory Care Centers, Others) 6.2.5. By Company (2021) 6.2.6. By Region 6.3. Product Market Map 7. Asia-Pacific Syringes Market Outlook 8. Europe Syringes Market Outlook 9. North America Syringes Market Outlook 10. South America Syringes Market Outlook 11. Middle East and Africa Syringes Market Outlook 12. Market Dynamics 12.1. Drivers 12.2. Challenges 13. Market Trends & Developments 14. Competitive Landscape 14.1. Becton, Dickinson, and Company 14.2. Terumo Corporation 14.3. Medtronic plc 14.4. B. Braun Medical Inc. 14.5. Nipro Corporation 14.6. Hindustan Syringes & Medical Devices Limited 14.7. Gerresheimer AG 14.8. SCHOTT AG 14.9. CODAN Medizinische Gerate GmbH & Co KG 14.10. Baxter International, Inc. 14.11. West Pharmaceutical Services, Inc. 14.12. Retractable Technologies, Inc. 14.13. Biocon Limited 14.14. Owen Mumford Ltd 14.15. Shandong Weigao Group Medical Polymer Co., Ltd. 15. Strategic Recommendations For more information about this report visit https://www.researchandmarkets.com/r/p9dir9

(Bloomberg) -- After a gut-wrenching bout of turbulence and existential angst, digital-asset investors are back to focusing on the mood of the US stock market as a gauge of whether the worst might be over. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Infla

Operating profits rose 39%, thanks to insurance and railroad businesses. Warren Buffett slowed buybacks and stock purchases.

(Bloomberg) -- Oil shook off an early slump at the week’s open to trade higher as investors weighed up prospects for demand ahead of a barrage of intelligence from leading energy players on the market outlook.Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS In

(Bloomberg) -- In his first week as Peru’s finance minister, Kurt Burneo plans to visit the central bank board and the head of congress with a basic message: Public investment must be increased to stimulate private activity.Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and E

Japanese bank lending rose 1.8% in July from a year earlier, accelerating from the previous month, as some companies borrowed more to meet rising raw material costs amid a surge in global commodity inflation. Outstanding loans held by the country's four main categories of banks, including "shinkin" or credit unions, hit a record 588.232 trillion yen ($4.36 trillion), Bank of Japan (BOJ) data showed on Monday. The increase, which followed a revised 1.2% gain in June, reflected rising fund demand for property investment as well as mergers and acquisitions, a BOJ official told a briefing.

BEIJING (Reuters) -China's export growth unexpectedly picked up speed in July, offering an encouraging boost to the economy as its struggles to recover from a COVID-induced slump, but weakening global demand could start to drag on shipments in coming months. Exports rose 18.0% in July from a year earlier, the fastest pace this year, official customs data showed on Sunday, compared with a 17.9% increase in June and beating analysts' expectations for a 15.0% gain.

The focus on China's actions toward Taiwan puts the spotlight on the chip industry, and these are stocks to keep on the radar for possible volatility.

Less than 1% of employees have taken the CEO’s buyout offer since he laid down the law on culture. Is Kraken a “based” place to work, or just somewhere to ride out crypto winter?

The Apple (AAPL) empire might be spearheaded by its flagship product, the iPhone, but along with plenty of other hardware offerings, its Services segment has been growing at a fast pace. There’s also talk of a “game changing” AV/VR headset and even of an Apple Car at some point. But Needham analyst Laura Martin thinks there’s also the prospect of another big revenue stream. “We believe AAPL is in the early stages of building a new mobile advertising platform,” says Martin, who thinks ad revenue

As a Chinese success story, Alibaba is unrivalled. As its founder, Jack Ma soared in power and prestige, acquiring a global reputation that spread alongside the company’s growth into a global e-commerce giant.

Square stock bulls focus on its Cash App and Afterpay synergies but bears worry over Bitcoin and a possible recession.

Several states have seen gasoline prices drop to three bucks or lower as crude oil prices have continued to decline.

Warren Buffett's company reported a $43.76 billion loss in the second quarter as the paper value of its investments plummeted and he bought significantly fewer stocks, but Berkshire Hathaway's many operating companies generally performed well.

In May, Frontdoor reported quarterly earnings that were significantly hampered by inflationary pressures and trends in the housing market. Three months later, not much has changed — because once again, these macroeconomic conditions have affected the home service provider’s performance. During a Q2 earnings call on Aug. 4, Frontdoor executives detailed the company’s latest results.

After July’s exceptional surge, the markets steadied during early August with the S&P 500 up by a third of a precent over the past week. Now investors will be keen to find out if the rally has legs. Stifel's chief equity strategist Barry Bannister thinks it does and believes the S&P 500 is on course to reach 4,400 during the year’s second half, explaining that the sell-off in 1H22 is “still being reversed.” The strategist also thinks the S&P 500’s “equity risk premium” now suggests a mid-point p

A hot July jobs report did not show the typical recessionary dynamics of widespread layoffs, but bond markets continued to flash worries over a hard landing as the Fed raises rates.

The dollar extended it best rally against the yen since mid-June on Monday, buoyed by higher Treasury yields after blockbuster U.S. jobs data lifted expectations for more aggressive Federal Reserve policy tightening. The greenback was last 0.31% higher at 135.42 yen, and earlier rose to 135.585 yen, its highest since July 28, after surging 1.57% in the previous session, its biggest single-day gain since June 17. Traders currently see a 73.5% probability the Fed continues the pace of 75 basis-point interest-rate increases for its next policy decision on Sept. 21, from about 41% before surprisingly strong payrolls data on Friday raised worries that wage growth would fuel inflationary pressures.

The package would pump billions of dollars into energy and healthcare programs over the next 10 years, including $430 billion in new spending.

(Bloomberg) -- Loomis, Sayles & Co. sued Citigroup Inc., alleging the bank caused more than $70 million in losses while executing two separate trading orders that swamped the market.Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillUS Inflation Peak in Sight But D

Senate Democrats wanted to change the tax rate on carried-interest income. The industry lobby knew how to push back.